Afuco™ Anti-CGRP ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-429CQ) (CAT#: AFC-TAB-429CQ)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CGRP. It is a humanized monoclonal antibody that can be potentially used in the treatment of Osteoarthritis (OA). It binds to and inhibits the activity of CGRP.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Humanized
- Type
- ADCC enhanced antibody
- Specificity
- Human CALCA and CALCB
- Species Reactivity
- Human
- Applications
- ELISA, IHC, FC, IP, IF, Inhib
- Conjugate
- Unconjugated
- Generic Name
- Galcanezumab
- Related Disease
- Osteoarthritis (OA)
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- CALCA; calcitonin related polypeptide alpha; CT; KC; PCT; CGRP; CALC1; CGRP1; CGRP-I
- Gene ID
- 796
- UniProt ID
- P01258
Related Resources
Please refer to Galcanezumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Galcanezumab.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Galcanezumab"
DrugMonitor™ Anti-Galcanezumab Antibody (VS-1224-YC497)Galcanezumab is a humanized monoclonal antibody against human CGRP, approved for preventing migraines and treating episodic cluster headaches. The DrugMonitor™ Anti-Galcanezumab Antibody (VS-1224-YC497) is an anti-drug antibody (ADA) against Galcanezumab. This drug-based antibody is raised in mice immunized with the Galcanezumab. The anti-Galcanezumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Galcanezumab in samples.
See other products for "CALCA and CALCB"
Select a product category from the dropdown menu below to view related products.
Please select product type
ADCC Enhanced Antibody Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| AFC-TAB-425CQ | Afuco™ Anti-CGRP ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-425CQ) | ELISA, IHC, FC, IP, IF, Inhib | ADCC enhanced antibody |
| AFC-TAB-428CQ | Afuco™ Anti-CGRP ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-428CQ) | ELISA, IHC, FC, IP, IF, Inhib | ADCC enhanced antibody |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-429CQ. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: WB, IP, IF, FuncS, FC, Neut, ELISA
Application:
Application: FC, IB, Block, Inhib, FuncS, ELISA, FACS, IP, IF
Application: Neut, FC
Application: WB, ELISA, FuncS, IB, FC, SPR, Apop
-3.jpg)
Application: Neut
Application: WB, ELISA, FC, IHC, IF, IP
Application: ELISA, WB, Microarray, Block
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
